+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Glatiramer Acetate"

Multiple Sclerosis Drugs - Global Strategic Business Report - Product Thumbnail Image

Multiple Sclerosis Drugs - Global Strategic Business Report

  • Report
  • April 2025
  • 235 Pages
  • Global
From
Multiple Sclerosis Drugs Market Report 2025 - Product Thumbnail Image

Multiple Sclerosis Drugs Market Report 2025

  • Report
  • April 2025
  • 250 Pages
  • Global
From
Generic Central Nervous System Drugs Market Report 2025 - Product Thumbnail Image

Generic Central Nervous System Drugs Market Report 2025

  • Report
  • March 2025
  • 175 Pages
  • Global
From
From
Multiple Sclerosis Drugs Market Analysis & Forecast to 2024-2034 - Product Thumbnail Image

Multiple Sclerosis Drugs Market Analysis & Forecast to 2024-2034

  • Report
  • January 2024
  • 200 Pages
  • Global
From
From
Neuroprotection - Methods, Drugs, Markets and Companies - Product Thumbnail Image

Neuroprotection - Methods, Drugs, Markets and Companies

  • Report
  • November 2021
  • 844 Pages
  • Global
From
  • 9 Results (Page 1 of 1)
Loading Indicator

Glatiramer acetate is a synthetic drug used to treat multiple sclerosis (MS). It is a mixture of four amino acids that are similar to those found in myelin, the protective sheath that covers nerve fibers. The drug works by reducing the inflammation and damage to the myelin sheath caused by MS. It is administered as an injection and is usually taken once a day. Glatiramer acetate is a relatively new drug, but it has become increasingly popular in the Central Nervous System (CNS) drugs market. It is used to treat relapsing-remitting MS, a form of the disease that is characterized by periods of remission and relapse. It is also used to treat primary progressive MS, a form of the disease that is characterized by a gradual worsening of symptoms. Glatiramer acetate is available in both generic and branded forms. Some of the companies that produce glatiramer acetate include Teva Pharmaceuticals, Mylan, and Sandoz. Show Less Read more